Anna Eshoo: “The PBM Accountability Act will finally shed a light on the opaque drug pricing system.”

Simply put, we are not getting the best value for our healthcare dollar.

This is, as you said and have said many times, this is a devastating disease, and I don't think this can be treated as 17 months of a little additional hope.

I see, as I expressed to you when we spoke, a disconnect between CMS, the FDA, and the VA on new treatments for mild Alzheimer's.

Spectrum is the gold in the 21st century. Nothing moves without spectrum.